Your account is not claimed yet. You can sign up with ORCID to claim your account.

Matejka Rebolj (M Rebolj)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 29

Top Venues

International journal of cancer

British journal of cancer

BJOG : an international journal of obstetrics and gynaecology

Journal of clinical microbiology

Queen Mary University of London

Erasmus MC (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Queen Mary University of London Jun 1o 2016

United Kingdom

Senior Epidemiologist :: Wolfson Institute of Preventive Medicine

Education History

Erasmus MC Jul 1o 2002 - May 31o 2008

Netherlands

PHD :: Department of Public Health

Publications

Francesca Pesola, Matejka Rebolj, Peter Sasieni
Managing an Extension of Screening Intervals: Avoiding Boom and Bust in Health Care Workloads. International journal of cancer (2023)
Francesca Pesola, Matejka Rebolj, Peter Sasieni
Managing an extension of screening intervals: Avoiding boom and bust in health care workloads. International journal of cancer 152 (10) (2023)
Francesca Pesola, Matejka Rebolj, Peter Sasieni
Managing an extension of screening intervals: Avoiding boom and bust in health care workloads. International journal of cancer 152 (10) (2023)
Francesca Pesola, Matejka Rebolj, Peter Sasieni
Managing an extension of screening intervals: Avoiding boom and bust in health care workloads. International journal of cancer 152 (10) (2023)
Francesca Pesola, Matejka Rebolj, Peter Sasieni
Managing an extension of screening intervals: Avoiding boom and bust in health care workloads. International journal of cancer (2023)
Francesca Pesola, Matejka Rebolj, Peter Sasieni
Managing an extension of screening intervals: Avoiding boom and bust in health care workloads. International journal of cancer 152 (10) (2023)
Francesca Pesola, Matejka Rebolj, Peter Sasieni
Managing an extension of screening intervals: Avoiding boom and bust in health care workloads. International journal of cancer (2023)
Francesca Pesola, Matejka Rebolj, Peter Sasieni
Managing an extension of screening intervals: Avoiding boom and bust in health care workloads. International journal of cancer 152 (10) (2023)
Matejka Rebolj, Alexandra Sargent, Sisse Helle Njor, Kate Cuschieri
Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly. International journal of cancer (2022)
Matejka Rebolj, Christopher S Mathews, Karin Denton, null null
Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot. Cancer cytopathology 130 (7) (2022)
Matejka Rebolj, Kate Cuschieri, Christopher S Mathews, Francesca Pesola, Karin Denton, Henry C Kitchener, null null
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data. BMJ (Clinical research ed.) 377 (2022)
Matejka Rebolj, Christopher S Mathews, Francesca Pesola, Kate Cuschieri, Karin Denton, Henry Kitchener, null null
Age-specific outcomes from the first round of HPV screening in unvaccinated women: Observational study from the English cervical screening pilot. BJOG : an international journal of obstetrics and gynaecology 129 (8) (2022)
Alejandra Castañon, Matejka Rebolj, Francesca Pesola, Philippa Pearmain, Ruth Stubbs
COVID-19 disruption to cervical cancer screening in England. Journal of medical screening 29 (3) (2022)
Adam R Brentnall, Matejka Rebolj
Comments on: "Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening". International journal of cancer 151 (3) (2022)
Matejka Rebolj, Francesca Pesola, Christopher S Mathews, David Mesher, Kate Soldan, Henry C Kitchener
The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot. British journal of cancer 127 (2) (2022)
Emily A Burger, Inge M C M de Kok, James F O'Mahony, Matejka Rebolj, Erik E L Jansen, Daniel D de Bondt, James Killen, Sharon J B Hanley, Alejandra Castanon, Mary Caroline Regan, Jane J Kim, Karen Canfell, Megan A Smith
A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions. eLife 11 (2022)
James Alexander Doorbar, Christopher S Mathews, Karin Denton, Matejka Rebolj, Adam R Brentnall
Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statistics. BMC health services research 22 (1) (2022)
Matejka Rebolj, Christopher S Mathews, Francesca Pesola, Alejandra Castañon, Henry Kitchener, null null
Acceleration of cervical cancer diagnosis with human papillomavirus testing below age 30: Observational study. International journal of cancer 150 (9) (2021)
Susanne Fogh Jørgensen, Berit Andersen, Lone Kjeld Petersen, Matejka Rebolj, Sisse Helle Njor
Adherence to follow-up after the exit cervical cancer screening test at age 60-64: A nationwide register-based study. Cancer medicine (2021)
Susanne Fogh Jørgensen, Berit Andersen, Anders Lernevall, Matejka Rebolj, Sisse Helle Njor
Variations in pathways and resource use in follow-up after abnormal mammography screening: a nationwide register-based study. Breast cancer research and treatment 189 (2) (2021)
Leonardo I Green, Christopher S Mathews, Jo Waller, Henry Kitchener, Matejka Rebolj, null null
Attendance at early recall and colposcopy in routine cervical screening with human papillomavirus testing. International journal of cancer 148 (8) (2020)
Francesca Pesola, Matejka Rebolj, Leeson Simon, L Dunk, L Pickford, A Gjini, Peter D Sasieni
Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales. BJOG : an international journal of obstetrics and gynaecology 128 (7) (2020)
Matejka Rebolj, Janet Rimmer, Karin Denton, John Tidy, Christopher Mathews, Kay Ellis, John Smith, Chris Evans, Thomas Giles, Viki Frew, Xenia Tyler, Alexandra Sargent, Janet Parker, Miles Holbrook, Katherine Hunt, Penny Tidbury, Tanya Levine, David Smith, Julietta Patnick, Ruth Stubbs, Sue Moss, Henry Kitchener
Primary cervical screening with high risk human papillomavirus testing: observational study. BMJ (Clinical research ed.) 364 (2019)
Matejka Rebolj, Dharmishta Parmar, Roberta Maroni, Oleg Blyuss, Stephen W Duffy
Concurrent participation in screening for cervical, breast, and bowel cancer in England. Journal of medical screening 27 (1) (2019)
Matejka Rebolj, Valentina Assi, Adam Brentnall, Dharmishta Parmar, Stephen W Duffy
Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis. British journal of cancer 118 (12) (2018)
Matejka Rebolj, S Njor, E Lynge, S Preisler, D Ejegod, C Rygaard, J Bonde
Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening. Cytopathology : official journal of the British Society for Clinical Cytology 28 (5) (2018)
Matejka Rebolj, Adam Brentnall, Stephen W Duffy
Reply to 'Comment on 'Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis". British journal of cancer 119 (11) (2018)
J U H Lam, Matejka Rebolj, D M Ejegod, H Pedersen, C Rygaard, E Lynge, E Harder, L T Thomsen, S K Kjaer, J Bonde
Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders. Journal of clinical microbiology 55 (10) (2017)
Matejka Rebolj, Jesper Bonde, Sarah Preisler, Ditte Ejegod, Carsten Rygaard, Elsebeth Lynge
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays. Journal of clinical microbiology 54 (11) (2016)

Matejka Rebolj.css-eqlu8i{font-size:small;padding-left:4px;} (M Rebolj)

Publication Activity (10 Years)

Top Topics

Top Venues

Matejka Rebolj (M Rebolj)